CCO Oncology Podcast
Podcast autorstwa Clinical Care Options
Kategorie:
185 Odcinki
-
Relapsed/Refractory Multiple Myeloma: Role and Safety of Bispecific Antibodies
Opublikowany: 22.10.2024 -
Gastroenteropancreatic Neuroendocrine Tumors: Diagnosis, Findings, and Recommendations
Opublikowany: 16.10.2024 -
ESMO 2024 Congress Highlights in Gynecologic Cancer: New Data Informing Treatment of Ovarian, Endometrial, and Cervical Cancers
Opublikowany: 1.10.2024 -
A Cancer Conversation: Optimizing the Care of Patients With CLL Through a Deeper Understanding of BTK Inhibitor Resistance
Opublikowany: 30.09.2024 -
Available and Emerging Therapies for Progressive/Recurrent ROS1-Altered Advanced NSCLC
Opublikowany: 6.09.2024 -
Available Clinical Data and Approved First-line Treatments for ROS1-Altered Advanced NSCLC
Opublikowany: 5.09.2024 -
ROS1-Alterations and Molecular Testing in Advanced NSCLC
Opublikowany: 28.08.2024 -
Midyear Highlights of Key Data From 2024 Gynecologic Cancer Conferences Informing Treatment of Ovarian, Endometrial, and Cervical Cancers
Opublikowany: 5.08.2024 -
Next-Generation Therapeutics for HR+/HER2- Breast Cancer: Spotlight on SERDs
Opublikowany: 22.07.2024 -
Current Clinical Practice and NCCN Guidelines for CLL/SLL
Opublikowany: 18.07.2024 -
Congress to Clinic: Expert Takeaways on Emerging Data for MPNs
Opublikowany: 12.07.2024 -
CELMoDs: Spotlight on Therapeutic Approaches Targeting Protein Degradation Pathways
Opublikowany: 11.07.2024 -
Experts Discuss the Role of CDK4/6 Inhibitors in HR+/HER2- Breast Cancer
Opublikowany: 9.07.2024 -
Congress to Clinic: Expert Takeaways on Emerging Data for AML
Opublikowany: 8.07.2024 -
Congress to Clinic: Expert Takeaways on Emerging Data for MDS
Opublikowany: 5.07.2024 -
Experiences With Oral SERDs for HR+/HER2- Metastatic Breast Cancer
Opublikowany: 14.05.2024 -
Applying the Latest Evidence and NCCN Guideline Recommendations in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Opublikowany: 7.05.2024 -
Homologous Recombination Repair (HRR) Testing and Targeted Therapy in Prostate Cancer
Opublikowany: 28.03.2024 -
Real-world Perspectives on Novel HER2-Targeted and TROP-2–Directed Therapies in Advanced Breast Cancer
Opublikowany: 18.03.2024 -
Current Considerations for Adverse Event Management With HER3-Directed Agents
Opublikowany: 26.12.2023
Updates on new data and best practices in the care of patients with cancer across a wide variety of solid tumors and hematologic malignancies from Clinical Care Options. Gain practical clinical insights and strategies and earn CME/CE credit for selected episodes.
